[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"postoperative-chronic-pain\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:postoperative-chronic-pain":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,44,69],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":26,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100618386","incidence-and-risk-factors-of-postoperative-chronic-pain-in-patients-who-have-undergone-hallux-valgus-surgery-100618386",false,"NCT07330947","Incidence and Risk Factors of Postoperative Chronic Pain in Patients Who Have Undergone Hallux Valgus Surgery","Incidence and Risk Factors of Postoperative Chronic Pain in Patients Who Have Undergone Hallux Valgus Surgery in the UC-Christus Clinical Hospital","Inclusion Criteria:\n\n* Patients who underwent Hallux Valgus surgery at various centers within the UC Christus network from January 2021 to April 2024.\n\nExclusion Criteria:\n\n* Patients who had difficulty responding to follow-up from the UC Christus health network Pain Unit and\u002For who do not answer the telephone call","ALL","18 Years",{"count":19,"type":20},350,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to learn about the incidence and risk factors of postoperative chronic pain in adult patients who have undergone Hallux Valgus surgery (between january 2021 and december 2024). This will be assesed through scales and medical records information.\n\nThe main questions to be answered are:\n\n* How many patients who have undergone Hallux Valgus surgery are experiencing postoperative chronic pain.\n* What factors are there present in those who do experience chronic pain after surgery.\n\nAfter accepting the informed consent, participants will be asked to answer a Brief Pain Inventory Scale and a Risk Factor Questionnaire for Postoperative Chronic Pain.",[24,25],"Postoperative Chronic Pain","Hallux Valgus Surgery",[27,28,29,30],"Hallux Valgus surgery","postoperative chronic pain","risk factors","brief pain inventory","NOT_YET_RECRUITING","2026-05-26",{"date":34,"type":35},"2026-05-28","ACTUAL",{"date":37,"type":20},"2026-06-01",{"date":39,"type":20},"2026-12-30",{"name":41,"class":42},"Pontificia Universidad Catolica de Chile","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":16,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":55,"conditions":56,"keywords":57,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":43},"100602199","postoperative-chronic-pain-in-children-aged-8-to-17-100602199","NCT07120399","Postoperative Chronic Pain in Children Aged 8 to 17","Investigation of the Incidence of Postoperative Chronic Pain in Children Aged 8 to 17 Years","Inclusion Criteria:\n\n* Voluntary participation\n* Undergoing a surgical procedure under anesthesia at our hospital\n* Availability of complete patient data for a 6-month postoperative follow-up period\n\nExclusion Criteria:\n\n* Presence of speech or communication disorders\n* Development of postoperative complications\n* Undergoing any additional surgical procedure for any reason during the 6 months follow-up period\n* Having diagnosed psychiatric or neurological disorders\n* Having a pre-existing history of chronic or long-term pain","8 Years","17 Years",{"count":54,"type":20},323,"The objective of this study is to assess the incidence of chronic postoperative pain in pediatric patients aged 8 to 17 years following surgical procedures. Furthermore, it seeks to identify potential risk factors contributing to the development of such pain and to evaluate its long-term implications.",[24],[58,24,59],"Pain","Quality of Life","2025-08-12",{"date":62,"type":35},"2025-08-14",{"date":64,"type":20},"2025-08-15",{"date":66,"type":20},"2026-08-15",{"name":68,"class":42},"Kocaeli University",{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":4,"eligibilityCriteria":75,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":76,"enrollmentInfo":77,"targetDuration":4,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":4,"overallStatus":84,"whyStopped":4,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":43},"100575913","effect-of-esketamine-and-lidocaine-on-postoperative-chronic-pain-and-long-term-survival-in-patients-undergoing-hepatectomy-100575913","NCT06778460","Effect of Esketamine and Lidocaine on Postoperative Chronic Pain and Long-term Survival in Patients Undergoing Hepatectomy","Effect of Perioperative Continuous Intravenous Infusion of Esketamine and Lidocaine on Postoperative Chronic Pain and Long-term Survival in Patients Undergoing Hepatectomy","Inclusion Criteria:\n\n1. Aged 18-75 years;\n2. Scheduled for elective hepatectomy;\n3. ASA grade I-III.\n\nExclusion Criteria:\n\n1. Patients who have been intubated in the ICU following surgery and do not have a planned extubation within 6 hours postoperatively.\n2. Patients with a body weight less than 40 kg or greater than 100 kg.\n3. Patients with cardiac conduction system abnormalities (second- or third-degree atrioventricular block) or cardiac insufficiency (left ventricular ejection fraction \\\u003C 50%).\n4. Patients with severe hepatic insufficiency (alanine aminotransferase \\[ALT\\], aspartate aminotransferase \\[AST\\], or bilirubin levels more than 2.5 times the upper limit of normal) or renal insufficiency (creatinine clearance rate \\\u003C 60 mL\u002Fmin).\n5. Patients with a known hypersensitivity to the investigational drug.\n6. Patients with a history of long-term opioid abuse.\n7. Patients who are unable to communicate effectively.\n8. Patients with serious comorbid medical conditions, such as uncontrolled hypertension, coronary heart disease, intracranial vascular malformations, or acute asthma exacerbations.\n9. Patients with a history of epilepsy or a history of manic episodes.\n10. Pregnant or breastfeeding women.\n11. Patients with glaucoma.\n12. Patients with preoperative cognitive dysfunction, bipolar disorder, or other psychiatric disorders, including mental retardation.\n13. Patients with primary liver cancer in conjunction with malignant tumors of other organs (such as lung, kidney, intestine, etc.), or those with clinical symptoms or imaging findings suggestive of distant metastasis.","75 Years",{"count":78,"type":20},304,"INTERVENTIONAL",[81],"NA","This study is a further observation and follow-up of the patients enrolled in the registration number ChiCTR230007164430 to further evaluate the effect of long-term infusion of esketamine and lidocaine on postoperative chronic pain, long-term quality of life and survival rate in patients undergoing hepatectomy.",[24],"RECRUITING","2025-01-10",{"date":87,"type":35},"2025-01-16",{"date":89,"type":35},"2023-05-05",{"date":91,"type":20},"2027-03-31",{"name":93,"class":42},"West China Hospital"]